
    
      The investigational left heart lead, QuickFlex Model 1258T, will be implanted with a legally
      marketed St. Jude Medical cardiac resynchronization therapy implantable cardioverter
      defibrillator (CRT-D) device.

      Patients will be followed at Pre-Discharge, 1-Month, 3-Month,and then every 6 months until
      the end of the study.
    
  